Rodeo Therapeutics

Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases. Read more

Thong Le's photo - President & CEO of Rodeo Therapeutics

President & CEO

Thong Le

CEO Approval Rating

83/100

Founded:

2017

Status:

PrivateAcquisition Pending from Amgen, Inc.

RODEO THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Neotherix has been one of Rodeo Therapeutics's top competitors. Neotherix's headquarters is in York, England, and was founded in 2007. Neotherix is in the Health Care Services industry. Neotherix generates 15% of Rodeo Therapeutics's revenue.

Harbor Medtech is one of Rodeo Therapeutics's top rivals. Harbor Medtech is a Private company that was founded in Irvine, California in 2010. Like Rodeo Therapeutics, Harbor Medtech also operates in the Biotechnology field. Harbor Medtech has 15 more employees vs. Rodeo Therapeutics.

Biorez is perceived as one of Rodeo Therapeutics's biggest rivals. Biorez was founded in 2008, and is headquartered in New Haven, Connecticut. Biorez operates in the Pharmaceuticals industry. Biorez generates $4M less revenue vs. Rodeo Therapeutics.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 20 a good estimate for Rodeo Therapeutics's Employee count?

Rodeo Therapeutics Acquisitions

No recent acquisitions found related to Rodeo Therapeutics

Rodeo Therapeutics Funding History

Since Rodeo Therapeutics was founded in 2017, it has participated in 3 rounds of funding. In total Rodeo Therapeutics has raised $18.5M. Rodeo Therapeutics' last funding round was on Nov 2018 for a total of $8.9M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Nov 2018
$8.9M
-
Equity
Nov 2018
$3.7M
-
Series A
Jul 2017
$5.9M

Since Rodeo Therapeutics was founded in 2017, it has participated in 3 rounds of funding. In total Rodeo Therapeutics has raised $18.5M. Rodeo Therapeutics' last funding round was on Nov 2018 for a total of $8.9M

Rodeo Therapeutics Investments

No recent investments found related to Rodeo Therapeutics

Rodeo Therapeutics News

March 31, 2021GeekWire

Amgen to acquire Seattle biotech company Rodeo Therapeutics for $55M

The news: Pharmaceutical giant Amgen agreed to acquire Rodeo Therapeutics, a Seattle biotech startup ... See more »
March 31, 2021Crain's Cleveland Business

Amgen buys drug-development startup that has ties to CWRU's med school

The giant pharmaceutical company based in Thousand Oaks, Calif., said it will acquire all shares outs... See more »
March 31, 2021The Business Journals

Company started with CWRU research to be acquired by biopharma giant Amgen

The deal could include future contingent milestone payments worth up to $666 million.... See more »
March 30, 2021San Fernando Valley Business Journal

Amgen Buys Rodeo Therapeutics

Amgen Inc. on Tuesday announced plans to acquire Rodeo Therapeutics Corp., a private biopharmaceutica... See more »
April 2, 2019GeekWire

Seattle startup Rodeo Therapeutics raises more cash for regenerative medicine treatments

Seattle-based startup Rodeo Therapeutics is raising more cash for its work on tissue repair and regen... See more »
December 13, 2018GeekWire

Seattle biotech startup raises $3.7M to help the body regenerate tissue

Rodeo Therapeutics, a Seattle-based biotech startup that is creating therapies to help the body regen... See more »
July 25, 2017FierceBiotechIT

Regenerative biotech Rodeo gains WuXi, Lilly, AbbVie backing

Rodeo Therapeutics Corporation has got off a $5.9 million series A financing round with a list of VC ... See more »

Rodeo Therapeutics Press Releases

Social Media

Rodeo Therapeutics Headquarters

1616 Eastlake Ave E Suite 200

Seattle, Washington98102

206-957-7300

Driving Directions »

Trending Companies

Rodeo Therapeutics Summary

ABOUT

Overview

Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases. Rodeo Therapeutics was founded in 2017. Rodeo Therapeutics' headquarters is located in Seatt...

CEO

Rodeo Therapeutics's President & CEO, Thong Le, currently has an approval rating of 83%. Rodeo Therapeutics's primary competitors are Neotherix, Harbor Medtech & Biorez.

Frequently Asked Questions about Rodeo Therapeutics

  1. When was Rodeo Therapeutics founded?

    Rodeo Therapeutics was founded in 2017
  2. Who is Rodeo Therapeutics's CEO?

    Rodeo Therapeutics's CEO is Thong Le
  3. How much revenue does Rodeo Therapeutics generate?

    Rodeo Therapeutics generates $10M in revenue
  4. How much funding does Rodeo Therapeutics have?

    Rodeo Therapeutics has historically raised $18.5M in funding
  1. Where is Rodeo Therapeutics's headquarters?

    Rodeo Therapeutics's headquarters is in Seattle Washington, USA
  2. How many employees does Rodeo Therapeutics have?

    Rodeo Therapeutics has 20 employees
  3. What sector does Rodeo Therapeutics operate in?

    Rodeo Therapeutics is in Biotechnology
  4. Who are Rodeo Therapeutics's competitors?

    Rodeo Therapeutics's top competitors are Neotherix, Harbor Medtech, Biorez